Kerri S. Bevis, MD
Kerri S. Bevis, MD
Assistant Professor
University of Alabama at Birmingham
7134 Old Overton Club Dr.
Birmingham,
AL
USA
35242-2501
Papers:
128
Disease stabilization vs. response after bevacizumab treatment in recurrent ovarian cancer: how do we determine clinical efficacy?
328
Utilizing camelid-derived single domain antibodies to enhance immunotherapy of ovarian cancer
440
Survival and toxicity of a modified GOG 172 IP chemotherapy regimen in patients with ovarian, fallopian tube or primary peritoneal carcinoma